February 2005

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-02-02-2005
Volume 29
Issue 2

Pharmaceutical Science & Technology News

External Link - article-146228.pdf

Articles in this issue
Correcting the Course
Using Extrusion-Spheronization to Develop Controlled-Release Formulations of Azithromycin
Toward a Generic Approach for Stress Testing of Drug Substances and Drug Products
February 2005
Good Work and True: USP Prepares for Convention 2005
Contract Manufacturers Getting Squeezed
In the Spotlight-February 2005
Emerging Analytical Technology: Moving from the Lab to the Line
Drug Safety Fears May Limit Reimporting and Shape R&D
In Defense of USP Singlet Testing
Recent Videos
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Industry Outlook 2025: The Rising Prominence of AI in Pharma
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Gilead Treatment for PBC Granted EC Conditional Marketing Authorization

Patrick Lavery
February 21st 2025
Article

Seladelpar, which is marketed in the US as Livdelzi, was recommended for an orphan drug designation by CHMP in December 2024.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

TOP NEWS on grunge world map | Image Credit: © Sean K - stock.adobe.com

DSM-Firmenich CBD Product Shows Promise in OSD Forms, Study Says

Patrick Lavery
February 20th 2025
Article

A capsule formulation may offer more consistent and reliable uptake versus a syringe, while being less dependent on food intake.

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Felicity Thomas
May 28th 2024
Podcast

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

FDA Grants Full Approval for Symptomatic Tenosynovial Giant Cell Tumor Treatment

Patrick Lavery
February 18th 2025
Article

Tenosynovial giant cell tumor (TGCT) is rare and non-malignant, forming in or near joints, but which if left untreated can cause damage to joints and surrounding tissue, potentially leading to significant disability.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

EMA Earns EMAS Certification

Susan Haigney
February 17th 2025
Article

The agency has received certification with the Eco-Management and Audit Scheme for its commitment to environmental sustainability.